Mardi Dier, SVP and CFO at MADRIGAL PHARMACEUTICALS, INC. (MDGL), sold 516 shares at $323.04 ($167K) on 2025-03-10, disclosed to the SEC on 2025-03-12.
Scheduled sale ($167k) by SVP and CFO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $323.04 | 258 | $83K | 50.0% |
| 2 | $323.04 | 258 | $83K | 50.0% |
| Total | $323.04 avg | 516 | $167K | 100% |
| Filing → |
| MDGL | SELL | 2025-12-03 | $3.6M | — | Filing → |
| MDGL | SELL | 2025-03-05 | $1.3M | — | Filing → |
| SLRN | BUY | 2023-05-11 | $116K | — | Filing → |